Home > Insider Trading > Filing (0000904454-12-000040)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1402023	L.p. (Delaware) Iii Ventures Index	No. 1 Seaton Place St. Helier, Channel Islands Y9 JE48YJ	No	No	Yes	No
1447764	Branch Jersey L.p. Partners Yucca	The Ogier House, The Esplanade St. Helier, Channel Islands Y9 JE49WG	No	No	Yes	No
1503681	L.p. (Jersey) Fund Entrepreneur Parallel Iii Ventures Index	No. 1 Seaton Place St. Helier, Channel Islands Y9 JE48YJ	No	No	Yes	No
1503683	Ltd Iii Associates Venture Index	No. 1 Seaton Place St. Helier, Channel Islands Y9 JE48YJ	No	No	Yes	No
1503686	L.p. (Jersey) Iii Ventures Index	No. 1 Seaton Place St. Helier, Channel Islands Y9 JE48YJ	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-30	50,000	$17.08	2,081,827	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Footnotes

These securities are owned directly by Index Ventures III (Jersey), L.P. ("IVIII Jersey"), Index Ventures III (Delaware), L.P. ("IVIII Delaware") and Index Ventures Parallel Entrepreneur Fund (Jersey), L.P. ("IVPEF"), of which Index Venture Associates III Ltd. is the general partner, and by Yucca Partners L.P. Jersey Branch as Administrator of the Index Co-Investment Scheme ("Yucca"). Index Venture Associates III Ltd. disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of its proportionate pecuniary interest therein.
Such shares of Common Stock were sold by IVIII Jersey.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.04 to $17.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
IVIII Jersey is the direct beneficial owner of 506,389 shares of Common Stock; IVIII Delaware is the direct beneficial owner of 1,541,886 shares of Common Stock; IVPEF is the direct beneficial owner of 21,273 shares of Common Stock; and Yucca is the direct beneficial owner of 12,279 shares of Common Stock.